Hidden attributes of zymosan in the pathogenesis of inflammatory diseases: A tale of the fungal agent

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 128

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-26-4_001

تاریخ نمایه سازی: 9 اسفند 1401

چکیده مقاله:

Inflammation triggers immune system-mediated actions that contribute to the development of multiple diseases. Zymosan, a polysaccharide derived from the Saccharomyces cerevisiae cell wall, is mainly made up of glucan and mannan residues and is used as an inflammatory agent. Zymosan is a fungal product that activates the immune system through the activation of inflammatory signaling pathways, and releases a variety of harmful chemicals including pattern recognition receptors, reactive oxygen species (ROS), and the excitatory amino acid glutamate, cytokines, adhesion molecules, etc. Furthermore, we will dive into the molecular mechanistic insights through which this fungal agent induces and influences various inflammatory diseases such as cardiovascular, neuroinflammation, diabetes, arthritis, and sepsis. Based on the evidence, zymosan appears to be a promising inflammatory-inducing agent. Nonetheless, more animal data is the need of the hour to catch a glimpse and unravel the capacity of zymosan.

نویسندگان

Priyanka Arya

Galgotias College of Pharmacy, Greater Noida, U.P., India

Neeraj Kumar

Galgotias College of Pharmacy, Greater Noida, U.P., India

Uma Bhandari

Department of Pharmacology, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard, New Delhi-۱۱۰۰۶۲

Surabhi Thapliyal

Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh ۲۴۹۲۰۳, India

Vikram Sharma

Galgotias College of Pharmacy, Greater Noida, U.P., India

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Chen L, Deng H, Cui H, Fang J, Zuo Z, ...
  • Fitzpatrick FW, DiCarlo FJ: Zymosan. Ann N Y Acad Sci ...
  • Venkatachalam G, Arumugam S, Doble M. Synthesis, characterization, and biological ...
  • Frasnelli ME, Tarussio D, Chobaz-Péclat V, Busso N, So A. ...
  • Dharavath RN, Kumar V, Chopra K. Zymosan A an Old ...
  • Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and ...
  • Harrigan TJ, Abdullaev IF, Jourd’heuil D, Mongin AA. Activation of ...
  • Pini M and Fantuzzi G. Enhanced production of IL-۱۷A during ...
  • https://clinicaltrials.gov/ct۲/show/NCT۰۴۶۷۴۳۰۶۱۱. Mallah K, Couch C, Borucki DM, Toutonji A, Alshareef ...
  • DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: The devil is ...
  • Abraham J. and Johnson R. W. Consuming a diet supplemented ...
  • Perry VH and Holmes C. Microglial priming in neurodegenerative disease. ...
  • Rehman Muhammad Saif-ur. The potential of toll-like receptors to modulate ...
  • Avital Luz , Nina Fainstein , Ofira Einstein , Tamir ...
  • Kamila Saganová , Jozef Burda, Judita Orendácová, Dása Cízková, Ivo ...
  • David L Schonberg, Phillip G Popovich, Dana M McTigue. Oligodendrocyte ...
  • Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad ...
  • Dalpke AH, Schäfer MK, Frey M, Zimmermann S, Tebbe J, ...
  • Lax N, Fainstein N, Nishri Y, Ben-Zvi A, Ben-Hur T. ...
  • Gonçalves RC, Carvalho CC, Michels M, Abatti MR, Manfredini A, ...
  • Pöyhönen Suvi, Er Safak, Domanskyi Andrii, Airavaara Mikko. Effects of ...
  • Sandra Moreira Rocha, Ana Clara Cristovão, Filipa Lopes Campos, Carla ...
  • Madan M and Amar S. Toll-like receptor-۲ mediates diet and/or ...
  • Arya Priyanka, Nabi Sayima, Bhandari Uma. Modulatory role of atorvastatin ...
  • Zhang YG, Zhang HG, Zhang GY, Fan JS, Li XH, ...
  • Liao W, Wei Y, Yu C, Zhou J, Li S, ...
  • Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in ...
  • Pini M, Gove ME, Sennello JA, van Baal JW, Chan ...
  • Szekanecz Z, Koch AE, Kunkel SL, Strieter RM. Cytokines in ...
  • Schorlemmer HU, Davies P, Hylton W, Gugic M, Allison AC. ...
  • Botwinski CA. Systemic inflammatory response syndrome. Neonatal Netw ۲۰۰۱; ۲۰: ...
  • Remirez D, González R, Merino N, Rodriguez S, Ancheta O. ...
  • Tunctan B, Korkmaz B, Sari AN, Kacan M, Unsal D, ...
  • Di Paola R, Mazzon E, Muia C, Crisafulli C, Genovese ...
  • Rooyackers OE, Saris WH, Soeters PB, Wagenmakers AJ. Prolonged changes ...
  • Minnaard R, Wagenmakers AJ, Combaret L, Attaix D, Drost MR, ...
  • Wang LY, Ku PM, Chen SH, Chung HH, Yu YM. ...
  • Volman TJ, Goris RJ, Lomme RM, DeGroot J, Verhofstad AA, ...
  • Iochida LC, Tominaga M, Matsumoto M, Sekikawa A, Sasaki H. ...
  • Davis JE, Braucher DR, Walker-Daniels J, Spurlock ME. Absence of ...
  • Novak M and Vetvicka V. β-glucans, history, and the present: ...
  • Volman TJ, Hendriks T, Goris RJ. Zymosan-induced generalized inflammation: Experimental ...
  • Volman TJ, Goris RJ, van der Jagt M, van de ...
  • Dimitrova P, Gyurkovska V, Shalova I, Saso L, Ivanovska N. ...
  • Mazur-Bialy AI, Kolaczkowska E, Plytycz B. Modulation of zymosan-induced peritonitis ...
  • Remichkova M, Yordanov M, Dimitrova P. Etoposide attenuates zymosan-induced shock ...
  • نمایش کامل مراجع